These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 13378052)
1. Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects. ACKERMAN IP; CONN JW; FAJANS SS; GITTLER RD; HENNES AR; JOHNSON RD; LOUIS LH; SELTZER HS; WAJCHENBERG BL Metabolism; 1956 Nov; 5(6 Part 2):820-39. PubMed ID: 13378052 [No Abstract] [Full Text] [Related]
2. Metabolic effects of arylsulfonylurea compounds in normal subjects and in diabetic patients. CONN JW; FAJANS SS; HENNES AR; WAJCHENBERG BL Diabetes; 1957; 6(1):41-3; discussion, 43-5. PubMed ID: 13397421 [No Abstract] [Full Text] [Related]
7. Effects of sulfonylurea drugs in hospitalized diabetic patients. RICKETTS HT; WILDBERGER HL J Am Med Assoc; 1956 Nov; 162(11):1045-9. PubMed ID: 13366706 [No Abstract] [Full Text] [Related]
8. The treatment of diabetic patients with the sulphonamide BZ-55. LINEHAN WD; NASH J J Ir Med Assoc; 1956 Oct; 39(232):109-11. PubMed ID: 13367546 [No Abstract] [Full Text] [Related]
9. Methods of selection of diabetic patients sensitive to sulfonylurea compounds. DUNCAN GG; JOINER CL; LEE CT Metabolism; 1956 Nov; 5(6 Part 2):964-71. PubMed ID: 13378066 [No Abstract] [Full Text] [Related]
10. Metabolic studies with the arylsulfonylureas. KUHL WJ Metabolism; 1956 Nov; 5(6 Part 2):953-63. PubMed ID: 13378065 [No Abstract] [Full Text] [Related]
11. [Treatment of diabetes mellitus with hypoglycemic sulfonamides]. BOULIN R Gaz Med Fr; 1957 Mar; 64(6):545-53. PubMed ID: 13427960 [No Abstract] [Full Text] [Related]
12. Diabetes mellitus. BERNHARD H Indian J Med Sci; 1957 Feb; 11(2):59-63. PubMed ID: 13428303 [No Abstract] [Full Text] [Related]
13. Symposium on clinical and experimental effects of sulfonylureas in diabetes mellitus; editorial statement. DUNCAN GG; LEVINE R Metabolism; 1956 Nov; 5(6 Part 2):721-6. PubMed ID: 13378038 [No Abstract] [Full Text] [Related]
14. Effect of sulfonylurea compounds in diabetic children. Camerini-Davalos R; Marble A; White P; Belmonte M; Sargeant L N Engl J Med; 1957 May; 256(18):817-22. PubMed ID: 13451946 [No Abstract] [Full Text] [Related]
16. Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus. ERK V; HAAR H; MCGAVACK TH; SEEGERS W Metabolism; 1956 Nov; 5(6 Part 2):919-32. PubMed ID: 13378061 [No Abstract] [Full Text] [Related]
17. Observations with sulfonylureas in diabetes. BROWN FR; FRISKEY RW; KINSELL LW; MICHAELS GD Metabolism; 1956 Nov; 5(6 Part 2):864-7. PubMed ID: 13378055 [No Abstract] [Full Text] [Related]
18. The use of orinase in diabetes. BEASER SB Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062 [No Abstract] [Full Text] [Related]
19. [Oral therapy of diabetes]. MELLINGHOFF CH Med Klin; 1956 Sep; 51(36):1497-502. PubMed ID: 13358558 [No Abstract] [Full Text] [Related]